Just in the previous decade, researchers have understood the big role that the microbes living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has actually been linked to numerous chronic illness, consisting of diabetes. An unbalanced microbiome structure has been discovered in patients with diabetes, who tend to have a less varied gut microbiome as compared to healthy individuals. Measurements Cm.
Some companies are developing diabetes treatments targeting the microbiome. The French Valviotis is presently performing preclinical testing of a drug targeted at increasing the microbiome diversity as a treatment for type 2 diabetes. Although promising, the microbiome field is extremely young and its intricacy makes it hard to establish causation after finding connection.
That world may not be up until now away, as many business are establishing non-invasive methods to replace finger pricking. Measurements Cm. Stability Applications has established a device called GlucoTrack that can determine glucose using electro-magnetic waves and is already offered in Europe. Similar innovations are appearing, with GlucoSense in London utilizing laser light to measure sugar levels and MediWise using radio waves.
The GlucoWise sensing unit prototypePatches are also becoming a popular type of determining blood sugar without needles, such as FreeStyle Libre, an inch-wide patch that can be worn for up to 2 weeks. At the University of Bath, scientists are developing a graphene patch that could offer greater precision by measuring sugar levels individually in multiple hair roots – Measurements Cm.
Meanwhile, Senseonic and Roche are working on a gadget that is implanted under the skin. Measurements Cm. Still, non-invasive alternatives to determine blood sugar level often deal with concerns regarding precision. The popular glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and even more developments will be required to reach the degree of precision of finger-pricking approaches.
Researchers are currently hypothesizing about microchips that can diagnose diabetes type 1 before the signs appear or nanorobots traveling in the blood stream while they determine glucose and provide insulin – Measurements Cm.”There’s little fiction left in this. I strongly think that microrobotics will come and will belong to our drug delivery within the next 10 years,” stated Tomas Landh, Director of Method and Development Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will undoubtedly make a huge difference in the lives of millions of individuals worldwide.